J. Goldman & Co’s LeonaBio Inc LONA Stock Holding History

J. Goldman & Co’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,745	Closed	-$641K	–	356
2022 Q1	$641K	Sell	4,745 -6,075	-56%	-$641K	0.03%	277
2021 Q4	$1.41M	Buy	+10,820	New	+$1.37M	0.08%	238

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

J. Goldman & Co's LONA Position: Q2 2022 in Review

J. Goldman & Co sold out of LeonaBio Inc (LONA) in Q2 2022, closing a stake of 4,745 shares — an estimated $641K sold.

J. Goldman & Co first reported a position in LONA in Q4 2021 and held it in 2 quarters. The position peaked at $1.41M in Q4 2021. 98 funds tracked by Wall St. Rank hold LONA as of Q2 2022.

J. Goldman & Co reported no remaining LeonaBio Inc position as of Q2 2022 after selling out during the quarter.
J. Goldman & Co sold 4,745 LeonaBio Inc shares in Q2 2022, an estimated $641K.
J. Goldman & Co first reported a position in LeonaBio Inc in Q4 2021 and held it in 2 quarters.
J. Goldman & Co's LeonaBio Inc position peaked at $1.41M in Q4 2021.
98 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2022.

Based on J. Goldman & Co's 13F filing for Q2 2022, filed 15 Aug 2022.